谷氨酸作为偏头痛治疗的治疗基质
Nazia Karsan1, Alves Luiza Bastos1, Peter J Goadsby1,2,3
1Headache Group, Wolfson Sensory, Pain and Regeneration Centre (SPaRC), Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 9PJ, UK.
International journal of molecular sciences
|April 17, 2025
概括
向谷氨酸通路,特别是谷氨酸受体,显示出治疗偏头痛和相关光环的希望. 需要进一步的研究,以克服药物输送和新偏头痛药物的疗效方面的挑战.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛是一种常见的神经疾病,其特点是剧烈的头痛,感官敏感性和恶心.
- 偏头痛的病理生理学被认为涉及谷氨酸,这是中枢神经系统 (CNS) 中的主要激发性神经递质.
- 谷氨酸与 nociception,中央敏感化和皮质扩散抑郁 (CSD) 有关,这是偏头痛中的关键过程.
研究的目的:
- 审查关于谷氨基胺基通路在偏头痛发病过程中的作用的文献.
- 探索向谷氨酸受体治疗偏头痛的治疗潜力.
- 讨论开发新型偏头痛药物的新发现和挑战.
主要方法:
- 进行了一项详尽的文献综述,研究的是甲基酸盐受体 (mGluRs) 和离子酸盐受体 (NMDA,AMPA,kainat).
- 审查审查了这些受体在偏头痛中的功能,包括它们在光环中的作用.
- 考虑了针对谷氨酸受体的治疗方法的临床前和早期临床结果.
主要成果:
- 谷氨酸向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向性向
- 代代类受体可能在像lamus和trigeminal核等大脑结构中的疼痛处理中发挥作用.
- 离子型受体有助于神经元过度兴奋,这是偏头痛的一个因素.
结论:
- 向谷氨酸受体为新型偏头痛治疗提供了一个有希望的途径.
- 仍然存在重大挑战,包括药物运输,副作用和整体疗效.
- 对分子机制,受体亚型和药物输送的持续研究对于临床转化至关重要.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
247
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
247
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
Ligand-gated Ion Channels
12.0K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators
260
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
260
Neurochemical Transmission: Sites of Drug Action
2.0K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.0K
Myasthenia Gravis: Overview and Treatment
967
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
967


